Central regions | Finance, business | Technology & innovation

HIV drug development under way, gets Skolkovo support

30 May '16
Viriom, a biomedical developer and asset of the ChemRar High Tech Center in Khimki outside Moscow, has been working on Russia’s first HIV solution which is expected to go beyond import substitution—an across-the-board goal the Russians have been pursuing in many sectors since the current crisis and western sanctions began—and offer “high potential for international commercialization.”

The new drug candidate’s safety, high efficacy and tolerance are said to have been proven during five rounds of phases 1 and 2 clinical trial testing. Phase 3 of clinical trials is currently under way in 18 AIDS prevention centers across Russia.

The Skolkovo Foundation, which is managing Russia’s most widely touted innovation hub just outside Moscow, earlier this year approved a new $2.2m grant for the next stage of the effort.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations:

Latest News: Central regions
21 Nov '17 | Finance, business | Technology & innovation
20 Nov '17 | Technology & innovation | Retail, FMCG
17 Nov '17 | Technology & innovation
15 Nov '17 | Technology & innovation | Finance, business
14 Nov '17 | Finance, business | Transport, logistics
 

Feature stories

21 Nov '17
Russian scientists have come up with what they say is...
7 Sep '17
26 Jul '17
Scientists at Tomsk Polytechnic (TPU) in Siberia have...
Search (News archive - 21193)
Advertising
Global_Entrepreneurship_Monitor
Advertising
Marchmont News

Latest News

21 Nov '17
Entrepreneurs who invest in start-ups may have their...
20 Nov '17
Moscow scientists have developed a cosmetic solution...
17 Nov '17
Three major Russian institutions—the Far East...

Most read stories from last week

20 Nov '17
Moscow scientists have developed a cosmetic solution...
21 Nov '17
Entrepreneurs who invest in start-ups may have their...
21 Nov '17
Russian scientists have come up with what they say is...